Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 1.5T | 1.3T | 1.4T | 1.2T |
Cost of revenue | 1.1T | 939.7B | 990.1B | 908.5B |
Gross profit | 405.2B | 343.4B | 365.4B | 300.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 118.9B | 117.2B | 129.7B | 99.8B |
Non operating interest income | ||||
Income | 8.7B | 6.0B | 6.8B | 5.1B |
Expense | 4.7B | 2B | 1.8B | 1.6B |
Other income expense | — | — | — | — |
Pretax income | 128.1B | 120.2B | 132.6B | 108.4B |
Tax provision | 39.3B | 28.7B | 46.0B | 31.1B |
Net income | 88.8B | 91.5B | 86.6B | 77.3B |
Basic EPS | — | — | — | 34.5 |
Diluted EPS | — | — | — | 34.5 |
Basic average shares | — | — | — | 1.9B |
Diluted average shares | — | — | — | 1.9B |
EBITDA | 187.6B | 171.4B | 184.9B | 151.9B |
Net income from continuing op. | 128.1B | 120.2B | 132.6B | 108.4B |
Minority interests | -19.1B | -22.8B | -24.4B | -10.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |